These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10773252)

  • 1. Tumor bed cyst formation after BCNU wafer implantation: report of two cases.
    Engelhard HH
    Surg Neurol; 2000 Mar; 53(3):220-4. PubMed ID: 10773252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
    McGirt MJ; Villavicencio AT; Bulsara KR; Friedman HS; Friedman AH
    J Neurosurg; 2002 May; 96(5):941-5. PubMed ID: 12005403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Symptomatic Cyst Formation after BCNU Wafer Implantation for Glioblastoma].
    Nakase K; Matsuda R; Nishimura F; Nakamura M; Motoyama Y; Park YS; Nakase H
    No Shinkei Geka; 2015 Aug; 43(8):747-52. PubMed ID: 26224470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.
    Subach BR; Witham TF; Kondziolka D; Lunsford LD; Bozik M; Schiff D
    Neurosurgery; 1999 Jul; 45(1):17-22; discussion 22-3. PubMed ID: 10414561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
    Engelhard HH
    Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
    Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
    Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
    J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
    Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
    J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
    Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
    J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
    Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
    Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
    Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
    J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
    Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
    Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
    Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
    World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas.
    Roux A; Ammar H; Moiraghi A; Peeters S; Baroud M; Zah-Bi G; Benzakoun J; Parraga E; Oppenheim C; Benevello C; Chretien F; Varlet P; Dhermain F; Dezamis E; Zanello M; Pallud J
    Neurosurg Rev; 2022 Apr; 45(2):1501-1511. PubMed ID: 34651215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
    Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
    Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
    Sabel M; Giese A
    Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric drug delivery for the treatment of glioblastoma.
    Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL
    Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.